Abstract:[Objective]To construct the recombinant adenovirus vector co-expressing human vascular endothelial growth fac-tor 165 (VEGF_(165)) and angiogenin-1 (Ang-1), and to observe the expression of target gene after transfection. [Method]Mo-lecular biologic techniques were used to clone the genes of VEGF_(165) and Ang-1, and PCR was used to amplify the DNA se-quence of IRES (internal ribozyme entry site) from pIRES2-EGFP. The genes of VEGF_(165), IRES and Ang-1 were subcloned to pTrack-CMV one by one to get the plasmid named pTrack-CMV-VIA, which contained all the three genes. The linearized shuttle plasmid was cotransformed into BJ5183 bacteria with backbone vector AdEasy-1. Further the recombinant plasmid was packaged and amplified in QBI-293A cells after Pac 1 digestion to get adenovirus vector pAd-VIA. The expression of the gene of interests was evaluated by fluorescence microscopic analysis of GFP expression and enzyme linked immunosorbent assay (ELISA). [Result]The recombinant adenovirus plasmid was consistent with that shown by sequencing and restriction endonucle-ases digestion. The recombinant pAd-VIA vector was packaged and amplified successfully in QBI-293A cells. The titer was 2 ×10~(10) PFU/ml after amplifying. High positive GFP was expressed in the field through fluorescence microscopy after being transfect-ed by recombinant pAd-VIA. ELISA indicated the expression of the target genes. The difference between the tansfected and non-transfected group was significant (P < 0.05). [Conclusion]The recombinant adenovirus vectors containing vascular endothelial growth factor 165 and angiopoietin-I were successfully constructed, thus providing convenient gene transfer tools for constructing the new gene-modified artificial bone.

[Construction of ADAMTS13-pEGFP-N1 vector and its expression in HeLa cells].

Construction of ADAM28 Gene Prokaryotic Expression Vector and Fusion Expression in E. Coli

[Stable Expression and Characterization of the Von Willebrand Factor Cleaving Protease].

[Expression of Vwf73 and VWF114 Fragments of Von Willebrand Factor A2 Domain and Their Utilization in Detecting ADAMTS13 Activity].

Construction and Eukaryotic Expression of ADAM9 Gene

Construction of recombinant adenovirus vector co-expressing angiopoietin-1 and report gene EGFP

Effect of Recombinant Protein in the Spacer Domain on ADAMTS13 Activity

The Expression And Regulation Of Adamts13 In Hematopoietic System.

The expression of ADAMTS13 in human microvascular endothelial cells.

Construction and Target Gene Expression of Recombinant Adenovirus Vectors Containing Vascular Endothelial Growth Factor 165 and Angiopoietin-1

Construction of Recombinant Adenoviral Vector Co-Expressing Vascular Cell Adhesion Molecules-1 and Enhanced Green Fluorescent Protein

Reconstruction and Identification of Adenovirus Expression Vector for Human Transforming Growth Factor Β1

[Construction of a Recombinant Adenoviral Vector Expressing Human Endostatin].

Construction and target gene expression of adenovirus vectors containing angiogenin-1/vascular endothelial growth factor 165

Expression of human vascular endothelial growth factor receptor Flt-1 extracellular domain 1-3 loop cDNA in Pichia pastoris, purification of the expressed product and detection of its biological activity.

Construction of Eukaryotic Expression Vector Pegfp-Vasp-lc and Its Expression in HeLa Cells

Construction and Characterization of the Recombinant Prokaryotic Vector Pgex-5X-3/mmp-11

Construction and Verification of Pegfp-N1-henos Recombinant Plasmid

Construction of recombinant eukaryotic expression vector pEGFPN1-GDNF and its expression

[Construction, Identification and Expression of Recombinant Eukaryotic Vector Pegfp-Bmi-1].

[Development of Hybridoma Cell Lines Secreting Monoclonal Antibodies Against ADAMTS13].